Allergan's acute migraine treatment wins US FDA approval

📆 12/23/2019 11:24 PM
📰 ChannelNewsAsia

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The U.S. Food and Drug Administration said on Monday it had approved Allergan Plc's drug for treating acute migraine in adults.

The drug, Ubrelvy, is the first oral version of a new class of drugs called CGRP inhibitors to win the FDA's approval for treating the neurological disease. The new class of drugs acts by interfering with CGRP, a protein involved in causing severe headaches.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines